Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...
Auteurs principaux: | Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Wiley
2022-10-01
|
Collection: | Pulmonary Circulation |
Sujets: | |
Accès en ligne: | https://doi.org/10.1002/pul2.12141 |
Documents similaires
-
The PH‐ILD Detection tool: External validation and use in patients with ILD
par: Raj Parikh, et autres
Publié: (2023-07-01) -
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
par: Julia McSweeney, et autres
Publié: (2023-04-01) -
Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
par: Aparna C. Swaminathan, et autres
Publié: (2024-11-01) -
Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
par: Jenna M. Faircloth, et autres
Publié: (2023-03-01) -
Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
par: Jenna M. Faircloth, et autres
Publié: (2023-08-01)